Ionis partners with Metagenomi to add gene editing to its broad technology platform

Collaboration with a leader in gene editing systems is Ionis' latest move to expand and diversify its technology CRISPR-Cas gene editing is a natural extension of Ionis' innovative approach to... | November 14, 2022

Related Keywords

Brianc Thomas , ,Exchange Commission ,Prnewswire Ionis Pharmaceuticals Inc ,Twitter ,Metagenomi Inc ,Ionis Pharmaceuticals Inc ,Ionis Pharmaceuticals ,Nasdaq ,Ionis Chief Executive Officer Brett ,Fargo Securities ,Nc Stock Exchange ,News ,Information ,Press Release ,Collaboration ,Ith ,Leader ,N ,Gene ,Editing ,Systems ,Us ,Latest ,Cove ,O ,Xpand ,End ,Diversify ,Its ,Technology ,Natural ,Extension ,F ,Nnovative ,Pproach Ions Us4622221004 ,